Bcl-B inhibitor 1

CAS No. 79220-88-5

Bcl-B inhibitor 1( —— )

Catalog No. M36960 CAS No. 79220-88-5

Bcl-B inhibitor 1 is an antitumor compound that binds to and inactivates pro-apoptotic proteins in the BH3 structural domain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 48 In Stock
50MG 63 In Stock
100MG 100 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bcl-B inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Bcl-B inhibitor 1 is an antitumor compound that binds to and inactivates pro-apoptotic proteins in the BH3 structural domain.
  • Description
    Bcl-B inhibitor 1 is a Bcl-B inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | BCL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79220-88-5
  • Formula Weight
    309.39
  • Molecular Formula
    C17H15N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S=C1N(C=C(N1)C2=CC=CC=C2)C3=CC=C(NC(C)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Siva Rajesh, et al. Computational designing of novel inhibitors to Bcl-B, an anti-apoptotic protein, using fragment-based drug designing approach. Romanian Biotechnological Letters 18(5):8613-8621.
molnova catalog
related products
  • Hinokitiol

    Hinokitiol (4-Isopropyltropolone;β-Thujaplicin) is a tropolone-related natural compound that can induces apoptosis and cell cycle arrest.

  • LCS3

    LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 μM and 3.8 μM, respectively.

  • 3'-Hydroxypterostilb...

    3'-Hydroxypterostilbene a natural pterostilbene analogue effectively inhibits the growth of human colon cancer cells with IC50s of 9.0 40.2 and 70.9 μM for COLO 205 HCT-116 and HT-29 cells respectively by inducing apoptosis and autophagy.